Milner Therapeutics Institute and LifeArc extend strategic partnership

Combines LifeArc’s translational expertise with the Milner’s cutting-edge bioinformatics

Accelerating progress against dementia 

How can we reduce the impact of dementia on individuals, families and wider society?

Learning from translational research success stories during the COVID-19 pandemic

Melanie Lee on how bringing together diverse teams united under a clear purpose can deliver extraordinary results.

Hackathon brings scientists together to tackle brain health

Together with the patient charity Motor Neurone Disease (MND) Association, LifeArc co-sponsored an MND challenge within a…

Covid-19 hub shortlisted for Scottish award

Unique translational research hub for Covid-19 and other viruses was a finalist in the Scottish Knowledge Exchange Awards. 

Living with genetic sight loss – a family story

Late-onset retinal degeneration (L-ORD) is a rare inherited eye disease that leads to blindness in older people.

Can an innovative gene therapy help people with Hunter syndrome?

Danny was diagnosed with Hunter syndrome when he was three years old.

Living with a rare but incurable liver disease

A young actor had to battle a rare liver disease before he could start out on his career.

LifeArc – advancing innovation in rare disease

We act as a trusted partner to transform the way rare diseases are identified and treated.